.png){kind=small}
.png){kind=small}
BackTable / Tumor Board / Contributor
Dr. Jonathan Mizrahi
Medical Oncologist
Dr. Jonathan Mizrahi is a medical oncologist with Ochsner Health in New Orleans, Louisiana.
Listen to Dr. Jonathan Mizrahi on the BackTable Podcast
The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Jonathan Mizrahi and get practical advice on how to build your practice by listening to the BackTable Podcast.
Stay Up To Date
Follow:
Subscribe:
Sign Up:
About Dr. Jonathan Mizrahi
Dr. Jonathan Mizrahi is a medical oncologist at Ochsner MD Anderson Cancer Center. He earned his undergraduate degree in economics from Harvard University and received his medical degree from the University of Florida College of Medicine in Gainesville, Florida. He completed his residency at Barnes-Jewish Hospital at Washington University Medical Center in St. Louis and his fellowship in hematology and oncology at MD Anderson Cancer Center in Houston. Dr. Mizrahi is board-certified in internal medicine, hematology and medical oncology by the American Board of Internal Medicine. He has been on staff at Ochsner since August 2020 and specializes in hematology and oncology, with a particular clinical and research focus on cancers of the gastrointestinal tract, including pancreatic cancer.
Podcasts Featuring Dr. Jonathan Mizrahi
.png){kind=small}
VI Episode #513
In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative to tyrosine kinase inhibitors and chemotherapy, making it an exciting time to be practicing oncology. In this episode, Dr. Tyler Sandow interviews oncology experts about the landscape of advanced hepatocellular carcinoma (HCC) and the current state of immunotherapy treatments. He is joined by medical oncologists Dr. Jonathan Mizrah, Dr. Lingling Du, and Dr. Adam Burgoyne, as well as interventional oncologist Dr. Zachary Berman.
.png){kind=small}
Tumor Board Episode #3
In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative to tyrosine kinase inhibitors and chemotherapy, making it an exciting time to be practicing oncology. In this episode, Dr. Tyler Sandow interviews oncology experts about the landscape of advanced hepatocellular carcinoma (HCC) and the current state of immunotherapy treatments. He is joined by medical oncologists Dr. Jonathan Mizrah, Dr. Lingling Du, and Dr. Adam Burgoyne, as well as interventional oncologist Dr. Zachary Berman.
Tumor Board Episode #1
Welcome to the first episode of BackTable Tumor Board, and our first recording session at our new in-person studio! Guest host Dr. Tyler Sandow (interventional radiologist) leads a multidisciplinary discussion about patient care coordination in hepatocellular carcinoma (HCC) diagnosis and treatment, with insights from his colleagues at Ochsner Health– Dr. Steven Young (hepatologist), Dr. Jonathan Mizrahi (medical oncologist), and Deondra Bonds-Adams (patient navigator).
VI Episode #509
Welcome to the first episode of BackTable Tumor Board, and our first recording session at our new in-person studio! Guest host Dr. Tyler Sandow (interventional radiologist) leads a multidisciplinary discussion about patient care coordination in hepatocellular carcinoma (HCC) diagnosis and treatment, with insights from his colleagues at Ochsner Health– Dr. Steven Young (hepatologist), Dr. Jonathan Mizrahi (medical oncologist), and Deondra Bonds-Adams (patient navigator).
Articles Featuring Dr. Jonathan Mizrahi
Tumor Board
Immunotherapy for HCC has transformed treatment for advanced liver cancer, with landmark trials like IMbrave150, Himalaya, and CheckMate-9DW redefining first-line options. Learn about these trials and their implications for survival benefits, combination strategies, and the role of tumor etiology.
Get in touch!
We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Podcasts
Topics
More Contributors
Dr. Aparna Baheti
Dr. Asad Baig
Dr. Michael Barraza
Dr. Christopher Beck
Dr. George Behrens
Dr. Zach Berman